Avient AI Stock Analysis
Avient (PY9) AI Stock Analysis
Avient
(Frankfurt:PY9)
No summary available
Avient (PY9) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 4.12B
- Dividend Yield
- 2.30%
- Average Volume (3M)
- 200
- Price to Earnings (P/E)
- 23.0
- Beta (1Y)
- 1.18
- Revenue Growth
- 0.04%
- EPS Growth
- 54.02%
- Country
- Germany
- Employees
- 9,000
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Avient Business Overview & Revenue Model
Company Description
Avient Corporation, established in 1885 and based in Avon Lake, Ohio, is a global enterprise specializing in advanced material solutions, custom formulation services, and sustainable products. The company, which operated as PolyOne Corporation until...
Avient Earnings Call Summary
The call was predominantly positive. Third-quarter results exceeded expectations, both operating segments delivered strong growth, margins expanded, the full-year outlook was raised, and debt reduction continued. The main challenges discussed were macroeconomic uncertainty, muted EMEA demand, modest overall volume growth, healthcare inventory rebalancing and the early stage of management's plans to accelerate growth.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For 2026, Avient now expects adjusted EBITDA to be in the range of $593 million to $603 million, adjusted EPS to be in the range of $3.22 to $3.32, and adjusted free cash flow to be in the range of $215 million to $230 million; its full year capital outlook is approximately $120 million versus $107 million invested in 2025, and net leverage is expected to exit 2026 in the range of 2.2 to 2.3 times compared to 2.6x at the end of 25. Raw material inflation is expected to be about mid-single-digit inflation on the total basket of raw materials, with hydrocarbon raw materials accounting for about 35% of raw material purchases; variable compensation is expected to be $30 million to $35 million, growth vectors are expected to be in the high single digits, really close to double digit, the core business will be in that GDP plus range, and the size of the growth vectors is in the range of $600 million.
Avient Risk Analysis
Avient disclosed 17 risk factors in its most recent earnings report. Avient reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
0 New RisksAvient Peers Comparison
Overall Rating
EMN65Neutral
ESI62Neutral
ASH61Neutral
CBT58Neutral
CC48Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 65Neutral | $7.61B | 11.66 | 10.63% | 5.12% | 0.40% | -6.58% | |
| 62Neutral | $8.26B | 39.53 | 7.39% | 0.96% | 39.62% | -14.83% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 61Neutral | $3.51B | 838.33 | 0.21% | 2.22% | 2.08% | ― | |
| 58Neutral | $3.71B | 17.69 | 13.35% | 2.56% | 0.83% | -33.11% | |
| 48Neutral | $2.07B | -12.13 | -117.69% | 2.62% | -0.51% | 49.73% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:PY9 | Avient Corporation | 40.80 | 15.79 | 63.14% | |
| ASH | Ashland Global Holdings, Inc. | 75.27 | 25.16 | 50.22% | |
| CBT | Cabot Corp | 72.17 | 12.03 | 20.01% | |
| EMN | Eastman Chemical Company | 65.61 | 8.23 | 14.34% | |
| ESI | Element Solutions | 33.32 | 7.68 | 29.93% | |
| CC | Chemours Company | 13.35 | 1.63 | 13.91% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
